Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease

B. E. Sands*, S. Bank, C. A. Sninsky, M. Robinson, S. Katz, J. W. Singleton, Jr Miner P.B., M. A. Safdi, S. Galandiuk, S. B. Hanauer, G. W. Varilek, A. L. Buchman, V. D. Rodgers, B. Salzberg, B. Cai, J. Loewy, M. F. Debruin, H. Rogge, M. Shapiro, U. S. Schwertschlag

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

198 Scopus citations

Fingerprint Dive into the research topics of 'Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences